Commercializing Biopharmaceutical Innovation In A New Era
The new era in biopharmaceutical development promises to usher in a slew of breakthrough medicines,...
Pfizer Shells Out $11.6 Bn. For Biohaven- Largest Since 2016
Pfizer will pay $11.6 billion for migraine medicine manufacturer Biohaven Pharmaceutical, signifying the company's largest...
Japan Drug Lobby Asserts Pricing Scheme Driving Drug Crisis
For the first time in the week starting May 16th, Japan's three major pharmaceutical trade...
Amid Global Setbacks, Indian Pharma Exports Grow In 2021-22
The Government of India recently announced that the pharmaceutical sector had its best-ever export performance in...
Samsung Biologics Reports First Quarter 2022 Financial Results
Samsung Biologics, the world’s leading contract development and manufacturing organization, announced strong financial results for...
Tong Ren Tang Technologies Co. Ltd. Strong Performance Revenue 5.4billion and Net Profit 867million...
With the strong support and promotion of the government, the traditional Chinese medicine industry has...
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2021 Financial Results
Samsung Biologics, the world’s leading contract development and manufacturing organization, announced strong financial results for...
Botanical Solution Inc Secures $6.1 Million in Series A First Closing
Botanical Solution Inc. (BSI), innovator of sustainable, consistent and cost-effective Advanced Botanical Materials for agricultural...
MasterControl Announces Annual Recurring Revenue Milestone
MasterControl, a global provider of software solutions for life sciences and other regulated industries, announced...
Aragen expects to ride wave of US biotech growth in 2022 – influx of...
Aragen Life Sciences (formerly, GVK BIO), a leading partner offering R&D and Manufacturing solutions (CRO/CDMO)...
